Skip to content

Clinical trials

Thyroid Cancer, Papillary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20034
20048
20052
20066
20075
20083
20091
20105
20116
20127
20133
20148
20157
20167
20172
20188
20196
202011
202114
202212
20237
202417
202511
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Unknown status29
Recruiting26
Active, not recruiting16
Not yet recruiting15
Terminated13
Enrolling by invitation1
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University6
Chinese PLA General Hospital4
Fujian Medical University4
Hoffmann-La Roche4
M.D. Anderson Cancer Center4
Massachusetts General Hospital4
University Health Network, Toronto4
Eli Lilly and Company3
Exelixis3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary183
Thyroid Neoplasms81
Adenocarcinoma, Follicular59
Carcinoma, Medullary27
Head and Neck Neoplasms22
Carcinoma, Non-Small-Cell Lung18
Thyroid Carcinoma, Anaplastic18
Lymphatic Metastasis13
Colonic Neoplasms12
Colorectal Neoplasms12

Trials

Showing 51 to 75 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.